Clinical Trial Update: A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2, single-arm, open-label exploratory trial evaluating adebrelimab (SHR-1316) in combination with chemotherapy for perioperative treatment of locally ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (SHR-1316) (adebrelimab)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Esophageal Cancer (EsC) | Phase 2 | Status: RECRUITING